Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

Cooper, N.J., Claxton, K. orcid.org/0000-0003-2002-4694, Chilcott, J. et al. (4 more authors) (2003) Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. BMJ. pp. 522-525. ISSN 1756-1833

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2003 BMJ Publishing Group Ltd
Dates:
  • Published: 8 March 2003
Institution: The University of York
Academic Units: The University of York > Economics and Related Studies (York)
The University of York > Faculty of Social Sciences (York) > Economics and Related Studies (York)
Depositing User: Sherpa Assistant
Date Deposited: 20 Nov 2006
Last Modified: 20 Aug 2017 00:16
Published Version: http://dx.doi.org/10.1136/bmj.326.7388.522
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmj.326.7388.522

Download

Filename: claxtonk4.pdf

Description: claxtonk4.pdf

Share / Export

Statistics